Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility

Revista Brasileira de Reumatologia

Volumn 51, Issue 6, 2011, Pages 587-602

  Mergener, Michelle ^a   Becker, Roze Mary Ribas ^a   dos Santos, Adriana Freitag ^a   dos Santos, Geraldine Alves ^b   de Andrade, Fabiana Michelsen ^c  

^a UNIVERSIDADE FEEVALE   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Environment; Fibromyalgia; Genetic polymorphism; Quality of life; Serotonin

Indexed keywords

2A SEROTONIN RECEPTOR GENE; ADULT; ARTICLE; CLIMATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; FIBROMYALGIA; GENE; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; NOISE; POLYMERASE CHAIN REACTION; QHOQOL 100 QUESTIONNAIRE; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL CARE; TRAFFIC; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDY;

SEROTONIN 2A RECEPTOR;

FEMALE; FIBROMYALGIA; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY OF LIFE; QUESTIONNAIRES; RECEPTOR, SEROTONIN, 5-HT2A; RETROSPECTIVE STUDIES;

EID: 82955194471     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician 2007; 76(2):247-54.
2. Fietta P, Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed 2007; 78(2):88-95.
3. Ablin JN, Cohen H, Buskila D. Mechanisms of disease: genetics of fibromyalgia. Nat Clin Pract Rheumatol 2006; 2(12):671-8.
4. Silva LC, Abreu AC, Pelegrino RS, Coelho OS. O valor da contagem de pontos dolorosos no diagnóstico clínico da fbromialgia. Rev Bras Reumatol 1997; 37(6):317-22.
5. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al. The American College of Rheumatology 1990 criteria for the classifcation of fbromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33(2):160-72.
6. Ribeiro LS, Coelho AM, Pádua AFM, Dias LL, Azevedo DC, Moura FM et al. Fibromyalgia and hepatitis C virus chronic infection: lack of association in two samples. Rev Bras Reumatol 2007; 47(2):97-105.
7. Ribeiro LS, Proietti FA. Fibromyalgia and infectious stress: possible associations between fbromyalgia syndrome and chronic viral infections. Rev Bras Reumatol 2005; 45(1):20-9.
8. Ferucci E, Collier DH. Fibromyalgia: diagnosis and treatment. Prim Care Case Rev 2002; 5(3):101-8.
9. Mehendale AW, Goldman MP. Fibromyalgia syndrome, idiopathic widespread persistent pain or syndrome of myalgic encephalomyelopathy (SME): what is its nature? Pain Pract 2002; 2(1):35-46.
10. Staud R, Domingo M. Evidence for abnormal pain processing in fbromyalgia syndrome. Pain Med 2001; 2(3):208-15.
11. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F. Increased rates of fbromyalgia following cervical spine injury: a controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997; 40(3):446-52.
12. Lee YH, Choi SJ, Ji JD, Song GG. Candidate gene studies of fbromyalgia: a systematic review and meta-analysis. Rheumatol Int 2010; 11:10-9.
13. Buskila D. Genetics of chronic pain states. Best Pract Res Clin Rheumatol 2007; 21(3):535-47.
14. Souza EJR, Nogueira-Machado JA, Silva FCL, Chaves MM, Costa DC. Avaliação da produção de espécies reativas de oxigênio por granulócitos de sangue periférico de pacientes com fbromialgia primária. Rev Bras Reumatol 2003; 43(6):337-42.
15. Giordano J, Schultea T. Serotonin 5-HT(3) receptor mediation of pain and anti-nociception: implications for clinical therapeutics. Pain Physician 2004; 7(1):141-7.
16. Sanders-Bush E, Fentress H, Hazelwood L. Serotonin 5-HT2 receptors: molecular and genomic diversity. Mol Interv 2003; 3(6):319-30.
17. Juhl JH. Fibromyalgia and the serotonin pathway. Altern Med Rev 1998; 3(5):367-75.
18. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fbromyalgia symptoms in the general population. J Rheumatol 1997; 24(3):555-9.
19. Russell IJ. Neurohormonal aspects of fbromyalgia syndrome. Rheum Dis Clinics North Am 1989; 15(1):149-68.
20. The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41(10):1403-9.
21. Fleck MPA. The World Health Organization instrument to evaluate quality of life (WHOQOL-100): characteristics and perspectives. Ciênc Saúde Coletiva 2000; 5(1):33-8.
22. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19(19):5444.
23. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK. A MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum Mol Genet 1993; 2(3):338.
24. Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993; 20(3):475-9.
25. Becker RM, Silva VK, Machado FS, Santos AF, Meireles DC, Mergener M et al. Interação entre qualidade do meio ambiente, estresse e a variação do gene APOE na determinação da suscetibilidade à fibromialgia. Rev Bras Reumatol 2010; 50(6):617-30.
26. Verbunt JA, Pernot DH, Smeets RJ. Disability and quality of life in patients with fbromyalgia. Health Qual Life Outcomes 2008; 6:8.
27. Pagano T, Matsutani LA, Ferreira EA, Marques AP, Pereira CA. Assessment of anxiety and quality of life in fbromyalgia patients. São Paulo Med J 2004; 122(6):252-8.
28. Valeikiene V, Ceremnych J, Alekna V, Juozulynas A. Differences in WHOQOL-100 domain scores in Parkinson's disease and osteoarthritis. Med Sci Monit 2008; 14(4):CR221-7.
29. Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43(12):1536-40.
30. van Houdenhove B, Neerinckx E, Onghena P, Lysens R, Vertommen H. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fbromyalgia. An etiological factor or proof of good citizenship? J Psychosom Res 2001;51(4):571-6.
31. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Krüger M, Schoeps P et al. Possible association of fibromyalgia with a polymorphism in serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42(11):2482-8.
32. Graeff FG. Serotonergic systems. Psychiatr Clin North Am 1997; 20(4):723-39.
33. Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B. Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fbromyalgia syndrome. Rheumatol Int 2001; 21(2):58-61.
34. Tander B, Gunes S, Boke O, Alayli G, Kara N, Bagci H et al. Polymorphisms of the serotonin-2A receptor and catecol-O-methyltransferase genes: a study on fbromyalgia susceptibility. Rheumatol Int 2008; 28(7):685-91.
35. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M et al. The T102C polymorphism of the 5-HT2A-receptor gene in fbromyalgia. Neurobiol Dis 1999; 6(5):433-9.
36. Matsuda JB, Barbosa FR, Morel LJ, França SDEC, Zingaretti SM, da Silva LM et al. Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fbromyalgia? Rev Bras Reumatol 2010; 50(2):141-9.
37. Lane HY, Liu YC, Huang CL, Hsieh CL, Chang YL, Chang L et al. Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults. J Psychiatry Neurosci 2008; 33(1):47-53.